Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting of benefit-risk assessments when incorporated within a clinical trial.
|Full bibliographic reference
|Totton N, Julious SA, Coates E, Hughes DA, Cook JA, Biggs K, Hewitt C, Day S, Cook A. Appropriate design and reporting of superiority, equivalence and non-inferiority clinical trials incorporating a benefit-risk assessment: the BRAINS study including expert workshop. Health Technol Assess. 2023;27(20):1-58.
(full-text if available)
|Read the full-text of the reporting recommendations.
Checklists have been developed for reporting the trial design and for reporting the trial results and these are available in appendix 5.
|Clinical trials, Experimental studies, Study protocols
|Applies to the whole report or to individual sections of the report?
|Harms/adverse effects/safety data, Procedure/Method, Results
|Record last updated on
|January 4, 2024
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.